Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / India/  Govt extends tenure of DCGI chief VG Somani by three months
BackBack

Govt extends tenure of DCGI chief VG Somani by three months

The union government is looking for a new candidate for the post of DCGI which works to ensure the quality of drugs and cosmetics sold in the country, gives approval for new drugs and regulates clinical trials

Drug Controller General of India Dr VG SomaniPremium
Drug Controller General of India Dr VG Somani

New Delhi

The Centre has extended the tenure of Drug Controller General of India VG Somani by three months. His term was set to end on 14 August 2022.

During the pandemic, the incumbent DCGI has played a key role from approval of covid-19 vaccines to approval of lifesaving drugs and ensuring its quality in combatting the covid-19 pandemic.

“It has been decided with the approval of the competent authority that Dr VG Somani, shall continue to hold the charge of the post of Drug Controller General of India (DCGI) under FR 49(v) for a period of three months w.e.f.16.8.2022 or until further order, whichever is earlier," said the union health ministry in an official order seen by Mint.

The union government is looking for a new candidate for the post of DCGI which works to ensure the quality of drugs and cosmetics sold in the country, gives approval for new drugs and regulates clinical trials.

In 2019, the government appointed Dr Somani as DCGI for a period of three years to head India’s apex drug regulatory agency Central Drugs Standard Control Organization (CDSCO). Prior to this in 2018, Dr S. Eswhara Reddy, joint drug controller, was holding the charge of DCGI on adhoc-basis. Presently, Reddy is in judicial custody over the alleged charges of corruption in Biocon bribery case.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

ABOUT THE AUTHOR
Priyanka Sharma
Priyanka Shamra is a health and pharma journalist with nearly nine years of field reporting experience. She is a special correspondent with Mint. Her beat includes covering the Ministry of Health and Department of Pharmaceuticals. She also covers the Ministry of Women and Child Development and the Department of Biotechnology.
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 17 Aug 2022, 05:11 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App